ITRAQ-based proteomics reveals novel biomarkers of osteoarthritis

Biomarkers

Volumn 18, Issue 7, 2013, Pages 565-572

  Ikeda, Daiki ^a,b   Ageta, Hiroshi ^b   Tsuchida, Kunihiro ^b   Yamada, Harumoto ^a  

^a FUJITA HEALTH UNIVERSITY HOSPITAL   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

BAALC; ITRAQ; LECT2; Osteoarthritis; PRDX6; Proteomics

Indexed keywords

BIOLOGICAL MARKER; BRAIN AND ACUTE LEUKEMIA CYTOPLASMIC; CHEMOTAXIN; LEUKOCYTE CELL DERIVED CHEMOTAXIN 2; PEPTIDES AND PROTEINS; PEROXIREDOXIN 6; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMUR NECK FRACTURE; HUMAN; HUMAN TISSUE; ISOBARIC TAGS FOR RELATIVE AND ABSOLUTE QUANTITATION METHOD; MALE; OSTEOARTHRITIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CASE-CONTROL STUDIES; FEMALE; FEMUR HEAD; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PEROXIREDOXIN VI; PROGNOSIS; PROTEOME; PROTEOMICS;

EID: 84888864944     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2013.810667     Document Type: Article

References (51)

1. Aggarwal K, Choe LH, Lee KH. (2006). Shotgun proteomics using the iTRAQ isobaric tags. Brief Funct Genomic Proteomic 5:112-20.
2. Anson M, Crain-Denoyelle AM, Baud V, et al. (2012). Oncogenic betacatenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J Clin Invest 122: 586-99.
3. Baldus CD, Tanner SM, Kusewitt DF, et al. (2003). BAALC, a novel marker of human hematopoietic progenitor cells. Exp Hematol 31: 1051-6.
4. Chambers G, Lawrie L, Cash P, Murray GI. (2000). Proteomics: A new approach to the study of disease. J Pathol 192:280-8.
5. Chen J, Lu XJ, Yang HY, Shi YH. (2010a). An interaction between a C-type lectin receptor and leukocyte cell-derived chemotaxin 2 of ayu, Plecoglossus altivelis. Fish Shellfish Immunol 28:245-8.
6. Chen WP, Bao JP, Hu PF, et al. (2010b). Alleviation of osteoarthritis by Trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis. Mol Biol Rep 37:3967-72.
7. Cillero-Pastor B, Eijkel GB, Kiss A, et al. (2013). Matrix-assisted laser desorption ionization-imaging mass spectrometry: A new methodology to study human osteoarthritic cartilage. Arthritis Rheum 65:710-20.
8. Conrozier T, Balblanc JC, Richette P, et al. (2012). Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study. J Orthop Res 30:679-85.
9. de Seny D, Sharif M, Fillet M, et al. (2011). Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Ann Rheum Dis 70:1144-52.
10. Dunn W, DuRaine G, Reddi AH. (2009). Profiling microRNA expression in bovine articular cartilage and implications for mechanotransduction. Arthritis Rheum 60:2333-9.
11. Fernandez-Costa C, Calamia V, Fernandez-Puente P, et al. (2012). Sequential depletion of human serum for the search of osteoarthritis biomarkers. Proteome Sci 10:55.
12. Fernandez-Puente P, Mateos J, Fernandez-Costa C, et al. (2011). Identification of a panel of novel serum osteoarthritis biomarkers. J Proteome Res 10:5095-101.
13. Franzoni A, Passon N, Fabbro D, et al. (2012). Histone post-translational modifications associated to BAALC expression in leukemic cells. Biochem Biophys Res Commun 417:721-5.
14. Gharbi M, Deberg M, Henrotin Y. (2011). Application for proteomic techniques in studying osteoarthritis: A review. Frontiers Physiol 2:90.
15. Gudbergsen H, Boesen M, Christensen R, et al. (2013). Changes in bone marrow lesions in response to weight-loss in obese knee osteoarthritis patients: A prospective cohort study. BMC Musculoskelet Disord 14: 106.
16. Henrotin Y, Gharbi M, Mazzucchelli G, et al. (2012). Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis. Arthritis Rheum 64:2260-7.
17. Hiraki Y, Inoue H, Kondo J, et al. (1996). A novel growth-promoting factor derived from fetal bovine cartilage, chondromodulin II. Purification and amino acid sequence. J Biol Chem 271:22657-62.
18. Hirata M, Kugimiya F, Fukai A, et al. (2012). C/EBPbeta and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2alpha as the inducer in chondrocytes. Hum Mol Genet 21: 1111-23.
19. JASSO, the Japan Society for the Study of Obesity. (2002). New criteria for obesity disease' in Japan. Circ J 66:987-92.
20. Jingushi S, Ohfuji S, Sofue M, et al. (2011). Osteoarthritis hip joints in Japan: Involvement of acetabular dysplasia. J Orthop Sci 16:156-64.
21. Kameoka Y, Yamagoe S, Hatano Y, et al. (2000). Val58Ile polymorphism of the neutrophil chemoattractant LECT2 and rheumatoid arthritis in the Japanese population. Arthritis Rheum 43:1419-20.
22. Kato S, Yamada H, Terada N, et al. (2005). Joint biomarkers in idiopathic femoral head osteonecrosis: Comparison with hip osteoarthritis. J Rheumatol 32:1518-23.
23. Kellgren JH, Lawrence JS. (1957). Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494-502.
24. Kong MK. (2012). Evaluation of a pretreatment method for two-dimensional gel electrophoresis of synovial fluid using cartilage oligomeric matrix protein as a marker. J Microbiol Biotechnol 22:654-8.
25. Koorts AM, Levay PF, Hall AN, et al. (2012). Expression of the H- and L-subunits of ferritin in bone marrow macrophages of patients with osteoarthritis. Exp Biol Med (Maywood) 237:688-93.
26. Kraus VB. (2011). Osteoarthritis year 2010 in review: Biochemical markers. Osteoarthritis Cartilage 19:346-53.
27. Kriegsmann M, Seeley E, Schwarting A, et al. (2012). MALDI MS imaging as a powerful tool for investigating synovial tissue. Scand J Rheumatol 41:305-9.
28. Langer C, Radmacher MD, Ruppert AS, et al. (2008). High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: A Cancer and Leukemia Group B (CALGB) study. Blood 111: 5371-9.
29. Okumura A, Saito T, Otani I, et al. (2008). Suppressive role of leukocyte cell-derived chemotaxin 2 in mouse anti-type II collagen antibodyinduced arthritis. Arthritis Rheum 58:413-21.
30. Ong HT, Tan PK, Wang SM, et al. (2011). The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic target. Cancer Gene Ther 18:399-406.
31. Ovejero C, Cavard C, Perianin A, et al. (2004). Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of betacatenin in the liver. Hepatology 40:167-76.
32. Relloso M, Puig-Kroger A, Pello OM, et al. (2002). DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGFbeta, and anti-inflammatory agents. J Immunol 168:2634-43.
33. Ross PL, Huang YN, Marchese JN, et al. (2004). Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3:1154-69.
34. Saito T, Fukai A, Mabuchi A, et al. (2010). Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med 16:678-86.
35. Saito T, Kawaguchi H. (2010). HIF-2alpha as a possible therapeutic target of osteoarthritis. Osteoarthritis Cartilage 18:1552-6.
36. Sato Y, Watanabe H, Kameyama H, et al. (2004). Serum LECT2 level as a prognostic indicator in acute liver failure. Transplant Proc 36: 2359-61.
37. Shukunami C, Kondo J, Wakai H, et al. (1999). Molecular cloning of mouse and bovine chondromodulin-II cDNAs and the growth-promoting actions of bovine recombinant protein. J Biochem 125:436-42.
38. Song X, Bandow J, Sherman J, et al. (2008). iTRAQ experimental design for plasma biomarker discovery. J Proteome Res 7:2952-8.
39. van Lent PL, Figdor CG, Barrera P, et al. (2003). Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells. Arthritis Rheum 48:360-9.
40. Wang MX, Wei A, Yuan J, et al. (2002). Expression and regulation of peroxiredoxin 5 in human osteoarthritis. FEBS Lett 531:359-62.
41. Wang Q, Rozelle AL, Lepus CM, et al. (2011a). Identification of a central role for complement in osteoarthritis. Nat Med 17:1674-9.
42. Wang Y, Li D, Xu N, et al. (2011b). Follistatin-like protein 1: A serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis. Arthritis Res Ther 13:R193.
43. WHO expert consultation. (2004). Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157-63.
44. Williams FM, Popham M, Hart DJ, et al. (2011). GDF5 single-nucleotide polymorphism rs143383 is associated with lumbar disc degeneration in Northern European women. Arthritis Rheum 63:708-12.
45. Wills AK, Black S, Cooper R, et al. (2012). Life course body mass index and risk of knee osteoarthritis at the age of 53 years: Evidence from the 1946 British birth cohort study. Ann Rheum Dis 71: 655-60.
46. Wilson R, Belluoccio D, Little CB, et al. (2008). Proteomic characterization of mouse cartilage degradation in vitro. Arthritis Rheum 58: 3120-31.
47. Wu Q, Zhu M, Rosier RN, et al. (2010). Beta-catenin, cartilage, and osteoarthritis. Ann N Y Acad Sci 1192:344-50.
48. Xie L, Lin AS, Kundu K, et al. (2012). Quantitative imaging of cartilage and bone morphology, reactive oxygen species, and vascularization in a rodent model of osteoarthritis. Arthritis Rheum 64: 1899-908.
49. Yamada H, Yoshihara Y, Henmi O, et al. (2009). Cementless total hip replacement: Past, present, and future. J Orthop Sci 14:228-41.
50. Yamagoe S, Yamakawa Y, Matsuo Y, et al. (1996). Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2. Immunol Lett 52:9-13.
51. Zhang XZ, Xiao ZF, Li C, et al. (2009). Triosephosphate isomerase and peroxiredoxin 6, two novel serum markers for human lung squamous cell carcinoma. Cancer Sci 100:2396-401.